Richard M. Stone

Research interests

Publications

• Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

  Blood · 2022 · https://doi.org/10.1182/blood.2022015853

• International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

  Blood · 2022 · https://doi.org/10.1182/blood.2022015850

• Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

  The Lancet Haematology · 2020 · https://doi.org/10.1016/s2352-3026(20)30205-2

• Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1817073

• Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity

  Cell · 2019 · https://doi.org/10.1016/j.cell.2019.01.031

• TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

  Leukemia · 2019 · https://doi.org/10.1038/s41375-018-0351-2

• Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1812836

• CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia

  Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2017.77.6112

• Durable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1716984

• Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms

  Science Translational Medicine · 2018 · https://doi.org/10.1126/scitranslmed.aan8292

• Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1614359

• Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

  Blood · 2017 · https://doi.org/10.1182/blood-2017-04-779405

• Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

  Cancer Discovery · 2016 · https://doi.org/10.1158/2159-8290.cd-16-0313

• International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

  Blood · 2015 · 10.1182/blood-2015-01-621664

• Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

  Blood · 2014 · 10.1182/blood-2014-11-610543

• Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

  Cancer Discovery · 2013 · 10.1158/2159-8290.cd-13-0609

• Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

  JAMA · 2009 · 10.1001/jama.2009.813

• Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

  Blood · 2009 · 10.1182/blood-2009-03-210039

• Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion

  New England Journal of Medicine · 2006 · https://doi.org/10.1056/nejmoa061292

• Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

  New England Journal of Medicine · 2006 · https://doi.org/10.1056/nejmoa062867

• Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412

  Blood · 2004 · https://doi.org/10.1182/blood-2004-03-0891

• A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

  New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa025217

• Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

  Journal of Clinical Oncology · 2002 · https://doi.org/10.1200/jco.2002.04.117

• United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia

  Journal of Clinical Oncology · 2001 · https://doi.org/10.1200/jco.2001.19.18.3852

• Report of an international working group to standardize response criteria for myelodysplastic syndromes.

  PubMed · 2000

Current projects

No projects listed.